Medicine and Dentistry
Antineoplastic Activity
66%
2 Methoxyestradiol
66%
Signal Transduction Pathway
66%
Estradiol
33%
Angiogenesis Inhibitor
33%
Neoplasm
33%
Solid Malignant Neoplasm
33%
Cell Type
33%
Metabolite
33%
Estrogen Receptor
33%
Multiple Myeloma
33%
Programmed Cell Death
33%
Sarcoma
33%
Microtubule
33%
Anticarcinogen
33%
Amino Terminal Sequence
33%
Tumor Cell
33%
Kinase Signaling
33%
Transcription Factor
33%
Antiangiogenic Activity
33%
Hypoxia Inducible Factor 1
33%
Introspection
33%
Evaluation Study
33%
Drug
33%
Chemotherapeutic Agent
33%
Aptitude
33%
Mechanism of Action
33%
Immunology and Microbiology
Spectrum
100%
Antineoplastic Activity
66%
2 Methoxyestradiol
66%
Multiple Myeloma
33%
Solid
33%
Amino Terminal Sequence
33%
Apoptosis
33%
Transcription Factor
33%
Tumor Cell
33%
Metabolite
33%
Microtubule
33%
Preclinical Study
33%
Hypoxia Inducible Factor 1
33%
Antiangiogenic Activity
33%
Introspection
33%
Cells
33%
Aptitude
33%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Preclinical Study
66%
Reactive Oxygen Metabolite
66%
2-Methoxyestradiol
66%
Neoplasm
33%
Angiogenesis Inhibitor
33%
Solid Malignant Neoplasm
33%
Anticarcinogen
33%
Diethylstilbestrol
33%
Multiple Myeloma
33%
Transcription Factor
33%
Sarcoma
33%
Hypoxia Inducible Factor 1
33%
Drug
33%
Chemistry
Spectra
100%
Antiangiogenic
66%
Antitumor
66%
Reactive Oxygen Species
66%
Estrogen
33%
Estradiol
33%
% Inhibition
33%
Antineoplastic Agent
33%
Mechanistic Study
33%
Signal Transduction
33%
Metabolite
33%
Apoptotic
33%
Solid
33%
Neuroscience
Reactive Oxygen Species
66%
2 Methoxyestradiol
66%
Apoptosis
33%
Transcription Factors
33%
Kinase
33%
Amino Terminal Sequence
33%
Estrogen Receptor
33%
Diethylstilbestrol
33%
Hypoxia Inducible Factor 1
33%